Koninklijke Philips/$PHG

1D1W1MYTD1Y5YMAX

About Koninklijke Philips

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Ticker
$PHG
Sector
Health
Primary listing
NYSE
Employees
63,670
Headquarters
Amsterdam, Netherlands
Website
www.philips.com

PHG Metrics

BasicAdvanced
$23B
18.52
$1.29
0.91
$0.84
3.53%

What the Analysts think about PHG

Analyst ratings (Buy, Hold, Sell) for Koninklijke Philips stock.
Analyst projections of the future price of Koninklijke Philips stock.

Bulls say / Bears say

Philips reported 4% comparable sales growth to €4.4 billion in Q2 2026, exceeding analyst expectations of 3.8% and demonstrating broad-based demand across its business segments (Reuters).
The company raised its full-year adjusted EBITA margin outlook to 13.5%–14.0% from 12.5%–13.0% and increased free cash flow guidance to €1.5–1.7 billion, driven by a €186 million US tariff refund benefit (Reuters).
Philips-led consortium was selected to support Region Stockholm’s hospital-at-home initiative under an up-to-eight-year contract to deliver advanced remote monitoring for up to 15,000 patients annually, expanding its connected care footprint (Reuters).
CEO Roy Jakobs noted that delayed orders in the US weighed on Q2 2026 results, underscoring potential volatility in its largest market where over 40% of sales are generated (Reuters).
China’s new centralized procurement policy announced in July 2026 has exerted pressure on Philips’ growth in that market, contributing to segment headwinds and potentially longer sales cycles (Reuters).
Philips’ comparable order intake declined 1% in Q2 2026 due to timing shifts of several large orders into the third quarter, signaling uneven demand for capital-intensive equipment (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2026.

PHG Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

PHG Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

PHG News

AllArticlesVideos

Southwest Mississippi Regional Medical Center Becomes First U.S. Hospital to Install Philips Rembra CT for Acute and High-Demand Imaging Environments

Business Wire2 weeks ago

Philips Launches Revolutionary Lumea® IPL 9900 Pro: the First At-Home Intense Pulsed Light (IPL) Hair Removal Device With Real-Time Audio Guidance That Talks to You During Treatment

Business Wire3 weeks ago

Philips, Shell targeted by hacking group

Reuters2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.